Literature DB >> 6054839

Regulation of bone resorption and formation. Influences of thyrocalcitonin, parathyroid hormone, neutral phosphate and vitamin D3.

M M Pechet, E Bobadilla, E L Carroll, R H Hesse.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6054839     DOI: 10.1016/0002-9343(67)90112-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  21 in total

1.  Aseptic necrosis in the femur after renal transplantation.

Authors:  W A Briggs; C L Hampers; J P Merrill; E B Hager; R E Wilson; A G Birtch; J E Murray
Journal:  Ann Surg       Date:  1972-02       Impact factor: 12.969

2.  The effect of pyrophosphate infusion on the response of the thyroparathyroidectomized rat to parathyroid hormone and adenosine-3',5'-cyclic monophosphate.

Authors:  A Delong; J Feinblatt; H Rasmussen
Journal:  Calcif Tissue Res       Date:  1971

3.  [Effect of parathyroid hormone on kidney function. I. Animal experiments].

Authors:  D Gekle
Journal:  Pflugers Arch       Date:  1971       Impact factor: 3.657

4.  The effect of calciferol, parathormone and calcitonin on the biochemical composition of kidney.

Authors:  A Komárková; I Bilyk; Z Záhor; V Czabanova
Journal:  Experientia       Date:  1972-04-15

5.  Simultaneous Mg, Ca, P, K and Cl analysis in rat tubular fluid. IV. During acute phosphate plasma loading.

Authors:  C Le Grimellec; N Roinel; F Morel
Journal:  Pflugers Arch       Date:  1974       Impact factor: 3.657

Review 6.  Calcitonin. A review of experimental and clinical investigations.

Authors:  G V Foster
Journal:  Postgrad Med J       Date:  1968-05       Impact factor: 2.401

7.  The effect of supplemental oral phosphate on the bone mineral changes during prolonged bed rest.

Authors:  S B Hulley; J M Vogel; C L Donaldson; J H Bayers; R J Friedman; S N Rosen
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

8.  Pseudohypoparathyroidism with raised plasma alkaline phosphatase.

Authors:  R D Cohen; F P Vince
Journal:  Arch Dis Child       Date:  1969-02       Impact factor: 3.791

9.  Metabolic bone disease in chronic renal failure. I. Dialyzed uremics.

Authors:  W E Huffer; D Kuzela; M M Popovtzer
Journal:  Am J Pathol       Date:  1975-03       Impact factor: 4.307

10.  Phosphate treatment of hypercalcaemia due to carcinoma.

Authors:  N Thalassinos; G F Joplin
Journal:  Br Med J       Date:  1968-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.